Mean Arterial Pressure (MAP) Calculator
Calculate MAP and pulse pressure from systolic and diastolic blood pressure. MAP represents the average arterial pressure throughout the cardiac cycle and is the primary determinant of organ perfusion — a critical target in shock, sepsis, and perioperative management.
Calculate Mean Arterial Pressure
Enter systolic and diastolic blood pressure to calculate MAP and pulse pressure. All values in mmHg.
This calculator uses the standard non-invasive estimation formula. Invasive arterial monitoring (arterial line) provides a directly measured MAP that is more accurate, particularly in patients with significant haemodynamic instability, arrhythmias, or very low cardiac output states. The non-invasive formula is an approximation that assumes a normal arterial waveform.
Understanding Mean Arterial Pressure
Mean arterial pressure represents the time-weighted average of arterial blood pressure over the entire cardiac cycle. Because diastole occupies roughly two-thirds of the cycle at normal heart rates, the MAP is weighted more towards the diastolic pressure than the systolic. MAP is the principal driving pressure for organ perfusion — it determines the effective pressure gradient that pushes blood through the capillary beds of the brain, kidneys, heart, and other vital organs.
Physiologically, MAP is the product of cardiac output (CO) and systemic vascular resistance (SVR): MAP = CO × SVR. This relationship is central to understanding hypotension — a low MAP can result from reduced cardiac output (hypovolaemia, cardiogenic shock), reduced vascular resistance (sepsis, anaphylaxis, neurogenic shock), or both. Treatment is directed at the underlying cause: volume for hypovolaemia, vasopressors for vasodilatory shock, inotropes for pump failure.
MAP Formula
MAP = DBP + ⅓(SBP − DBP)
Equivalent to: (SBP + 2 × DBP) ÷ 3
Example: SBP 120, DBP 80
= 80 + ⅓(120 − 80)
= 80 + 13.3
= 93 mmHg
Pulse Pressure
PP = SBP − DBP
Normal: 30–50 mmHg
Wide PP (>60): Aortic regurgitation, hyperthyroidism, arterial stiffness, high-output states
Narrow PP (<25): Cardiac tamponade, heart failure, aortic stenosis, hypovolaemia
Key concept: The ⅓ weighting towards pulse pressure (SBP − DBP) in the MAP formula reflects the fact that at a normal resting heart rate (~75 bpm), diastole lasts approximately twice as long as systole. At very high heart rates (e.g., >120 bpm), the systolic fraction of the cycle increases and the ⅓ approximation becomes less accurate — in tachycardic patients, a directly measured MAP (from an arterial line) is preferred.
Interpretation & Categories
MAP should be interpreted in the context of the patient’s baseline blood pressure, comorbidities, and clinical status. The table below provides general categories, though individual patients — particularly those with chronic hypertension — may tolerate different ranges.
| MAP (mmHg) | Category | Clinical Significance |
|---|---|---|
| < 60 | Critical Hypotension | Organ hypoperfusion is likely. Below the autoregulatory threshold for most vascular beds. Risk of acute kidney injury, cerebral ischaemia, and myocardial injury. Urgent intervention required. |
| 60–65 | Low — At Risk | Below the minimum target for sepsis resuscitation (MAP ≥65). May be tolerated briefly in young, healthy patients but is inadequate for patients with chronic hypertension, significant atherosclerosis, or acute illness. |
| 65–70 | Borderline Low | Minimum target in sepsis (Surviving Sepsis Campaign recommends MAP ≥65). May be acceptable as initial target in septic shock but some patients — particularly those with chronic hypertension — may require a higher target (MAP 80–85). |
| 70–100 | Normal | Within the physiological autoregulatory range for most organs. Adequate perfusion of brain, kidneys, and heart in the majority of patients. |
| 100–110 | Elevated | May be seen with stage 1 hypertension, pain, anxiety, or as a compensatory response. In most contexts, not immediately dangerous but warrants assessment of underlying cause. |
| > 110 | Hypertensive | Associated with stage 2 or stage 3 hypertension. Sustained values may indicate hypertensive urgency or emergency, particularly with end-organ damage (encephalopathy, AKI, aortic dissection, pulmonary oedema). |
MAP targets must be individualised. A patient with long-standing hypertension (baseline BP 160/90, MAP ~113) has a rightward-shifted autoregulatory curve — their organs have adapted to higher perfusion pressures. In such patients, a MAP of 65 mmHg that would be “adequate” in a young normotensive person may cause significant organ hypoperfusion. The Surviving Sepsis Campaign acknowledges that some patients may require a higher MAP target (80–85 mmHg).
MAP Targets & Clinical Applications
MAP is a central haemodynamic target across multiple clinical settings. Rather than targeting systolic BP alone, MAP provides a more reliable estimate of perfusion pressure because it accounts for the entire cardiac cycle. Below are the major clinical scenarios where MAP targets guide management.
The Surviving Sepsis Campaign (SSC) recommends an initial MAP target of ≥65 mmHg for patients with septic shock requiring vasopressors. This threshold was supported by the SEPSISPAM trial (2014), which randomised septic shock patients to MAP targets of 65–70 vs 80–85 mmHg and found no overall mortality difference. However, patients with pre-existing chronic hypertension in the higher-target group had less renal replacement therapy.
In practice, the initial target should be MAP ≥65, titrated upward based on clinical signs of adequate perfusion: urine output ≥0.5 mL/kg/h, improving lactate, adequate mental status, and resolving mottling. Patients with chronic hypertension may need a target of 80–85 mmHg. Noradrenaline (norepinephrine) is the first-line vasopressor.
Acute ischaemic stroke: Blood pressure is typically permitted to remain elevated (up to 220/120 mmHg) in the first 24–48 hours unless thrombolysis is planned, to maintain perfusion through collateral vessels to the ischaemic penumbra. If thrombolysis is given, BP should be maintained below 180/105 mmHg for 24 hours post-treatment.
Intracerebral haemorrhage (ICH): The INTERACT2 trial demonstrated that early intensive BP lowering to SBP <140 mmHg (MAP approximately 90–100 mmHg) is safe and may improve functional outcomes. Current guidelines recommend targeting SBP 130–150 mmHg in acute ICH.
Traumatic brain injury (TBI): Cerebral perfusion pressure (CPP = MAP − ICP) targets of 60–70 mmHg are recommended. This typically requires maintaining MAP at 80–90+ mmHg, depending on intracranial pressure. Avoiding hypotension (SBP <90 mmHg) is critical, as a single episode doubles mortality in severe TBI.
Intraoperative hypotension — commonly defined as MAP <65 mmHg or a >20% decline from baseline — is associated with myocardial injury, acute kidney injury, and increased 30-day mortality. The duration and depth of hypotension matter: even brief episodes below MAP 55 mmHg are associated with organ injury.
Most anaesthesia guidelines recommend maintaining intraoperative MAP within 20% of the patient’s baseline. For patients with chronic hypertension, this means tolerating a higher MAP floor. Vasopressors (phenylephrine, noradrenaline, vasopressin) and fluid management are titrated to maintain MAP above the individualised threshold. Point-of-care arterial line monitoring is standard for major surgical cases.
Renal autoregulation maintains relatively constant renal blood flow across a MAP range of approximately 60–160 mmHg in healthy individuals. Below this range, glomerular filtration falls and the risk of ischaemic AKI rises. In patients with chronic hypertension, CKD, or diabetes, the autoregulatory curve is shifted rightward — these patients may develop AKI at MAP values that would be tolerated by a normotensive individual.
In clinical practice, a MAP ≥65 mmHg is generally considered the minimum for adequate renal perfusion, but this threshold should be increased in patients with known CKD or chronic hypertension. Monitoring urine output (≥0.5 mL/kg/h) and serum creatinine are practical bedside indicators of renal perfusion adequacy.
While MAP reflects average perfusion pressure, pulse pressure (SBP − DBP) provides information about arterial compliance and stroke volume. A normal pulse pressure of 30–50 mmHg reflects healthy arterial elasticity and adequate stroke volume.
Wide pulse pressure (>60 mmHg) is seen in aortic regurgitation (bounding pulses, wide PP), arterial stiffness (isolated systolic hypertension in the elderly), high-output states (thyrotoxicosis, anaemia, pregnancy, sepsis with preserved cardiac output, arteriovenous fistula), and physiologically with exercise.
Narrow pulse pressure (<25 mmHg) suggests reduced stroke volume or increased peripheral vasoconstriction. It is characteristic of cardiac tamponade (pulsus paradoxus), severe aortic stenosis, constrictive pericarditis, cardiogenic shock, and significant hypovolaemia. A narrowing pulse pressure in the context of clinical deterioration may be an early sign of impending cardiovascular collapse.
MAP alone does not guarantee adequate tissue perfusion. A patient may have a normal MAP with maldistributed flow (as in sepsis with microvascular dysfunction). Always assess end-organ perfusion markers alongside MAP: mental status, urine output, serum lactate, capillary refill time, and skin mottling.
Common Pitfalls & Limitations
The standard formula (DBP + ⅓ PP) assumes that diastole occupies approximately two-thirds of the cardiac cycle, which holds true at normal heart rates (~60–80 bpm). In tachycardia (>100 bpm), systole occupies a proportionally larger fraction of the cycle, and the ⅓ weighting underestimates the true MAP. At very high heart rates (>120 bpm), the error becomes clinically significant.
In tachycardic or haemodynamically unstable patients, a directly measured MAP from an arterial line is preferred. If non-invasive monitoring is the only option, oscillometric monitors calculate MAP directly from the arterial waveform envelope and are more accurate than applying the manual formula to the displayed SBP/DBP values.
Applying a universal MAP target of 65 mmHg to all patients ignores the critical role of baseline blood pressure. A chronically hypertensive patient (baseline 170/100, MAP ~123) who develops septic shock will have a rightward-shifted cerebral and renal autoregulatory curve. Maintaining this patient at a MAP of 65 mmHg may cause significant cerebral and renal hypoperfusion, even though this value would be adequate for a previously normotensive individual.
The SEPSISPAM trial demonstrated that targeting a higher MAP (80–85 mmHg) in chronically hypertensive septic patients reduced the need for renal replacement therapy. Always document and consider the patient’s premorbid blood pressure when setting MAP targets.
MAP is a macrohaemodynamic parameter — it tells you about the pressure in the arterial system but nothing about the adequacy of microvascular flow or oxygen delivery at the tissue level. In distributive shock (sepsis), the MAP may be “adequate” while tissue perfusion remains severely compromised due to microvascular dysfunction, capillary leak, and flow maldistribution.
Always complement MAP monitoring with markers of tissue perfusion: serum lactate (trending toward clearance), central venous oxygen saturation (ScvO2 ≥70%), urine output (≥0.5 mL/kg/h), capillary refill time (<3 seconds), and skin assessment (mottling, temperature). A patient with a MAP of 70 mmHg and a rising lactate needs further intervention despite the “normal” MAP.
Non-invasive blood pressure (NIBP) measurement using oscillometric cuffs can be inaccurate in several clinical scenarios. An incorrectly sized cuff (too small = overestimates, too large = underestimates BP) is the most common source of error. Arrhythmias — particularly atrial fibrillation — cause beat-to-beat variation that reduces NIBP accuracy. Peripheral vasoconstriction (hypothermia, high-dose vasopressors) can lead to significant discrepancy between cuff and invasive measurements.
In critically ill patients, NIBP may underestimate true MAP by 5–15 mmHg compared to arterial line measurements. For patients requiring vasopressor titration or with haemodynamic instability, invasive arterial monitoring provides continuous, beat-to-beat MAP measurement and is the standard of care in intensive care and major surgery.
Quick Reference Summary
| Clinical Setting | MAP Target | Key Guideline |
|---|---|---|
| Septic shock (initial) | ≥ 65 mmHg | Surviving Sepsis Campaign 2021 |
| Septic shock (chronic HTN) | 80–85 mmHg | SEPSISPAM trial (Asfar 2014) |
| Intraoperative | Within 20% of baseline | ESA / ASA perioperative guidelines |
| Traumatic brain injury | CPP 60–70 (MAP ≥ 80+) | BTF Guidelines 4th Ed (2016) |
| Acute ischaemic stroke (no lysis) | Permissive (up to 220/120) | AHA/ASA 2019 Guidelines |
| Acute ischaemic stroke (post-lysis) | < 180/105 for 24 h | AHA/ASA 2019 Guidelines |
| Acute intracerebral haemorrhage | SBP 130–150 (MAP ~90–100) | INTERACT2 trial (Anderson 2013) |
MAP is the perfusion pressure — but pressure is not perfusion. Always combine MAP with clinical markers of organ perfusion (urine output, lactate, mental status, capillary refill) to assess haemodynamic adequacy. Individualise MAP targets based on the patient’s baseline blood pressure, comorbidities, and clinical context. A “one-size-fits-all” MAP of 65 mmHg is a starting point, not an end goal.
Disclaimer & References
For Educational Purposes Only. This calculator and the accompanying clinical information are intended as educational tools for healthcare professionals. They do not replace clinical judgement. Results should be interpreted in the full clinical context. Lab reference ranges vary by institution — verify with your own laboratory. Drug dosages should be confirmed against current prescribing information.
References
- Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Critical Care Medicine. 2021;49(11):e1063–e1143. DOI: 10.1097/CCM.0000000000005337
- Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. New England Journal of Medicine. 2014;370(17):1583–1593. DOI: 10.1056/NEJMoa1312173
- Salmasi V, Maheshwari K, Yang D, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery. Anesthesiology. 2017;126(1):47–65. DOI: 10.1097/ALN.0000000000001432
- Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. New England Journal of Medicine. 2013;368(25):2355–2365. DOI: 10.1056/NEJMoa1214609
- Carney N, Totten AM, O’Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017;80(1):6–15. DOI: 10.1227/NEU.0000000000001432
- Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update. Stroke. 2019;50(12):e344–e418. DOI: 10.1161/STR.0000000000000211
- Sessler DI, Bloomstone JA, Aronson S, et al. Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery. British Journal of Anaesthesia. 2019;122(5):563–574. DOI: 10.1016/j.bja.2019.01.013